11th Annual World Drug Manufacturing Summit - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

11th Annual World Drug Manufacturing Summit


11th Annual World Drug Manufacturing Summit
26-28th November 2012
Venue: Swissôtel, Düsseldorf, Germany
www.wdmsummit.com

The Annual World Drug Manufacturing Summit sources and presents leading global case studies from Pfizer, GSK, AstraZeneca, Baxter, Bayer and many more.

The Summit is packed full of real life pharma manufacturing case studies, allowing you to benchmark your business against ‘best in class’ and ensure that you have the tools you need to form a coherent and logical strategy.

Key issues include:

  • Lean deployment, Maintenance and Development
  • QbD Implementation
  • Quality Control & Management
  • Cost Reduction
  • Engineering principles, Facility Upgrade & Maintenance
  • Tech transfer & Scale-up
  • Control & Decision-making Software & Technology
  • Anti-counterfeiting & Serialization

If you have any questions about the new programme, would like to register your interest in speaking at WDM 2012, or would like to book your place please contact Richard Jones on +44 (0)20 7202 7690 or at Richard.jones@wtgevents.com. Please visit www.wdmsummit.com or to book now for the discounted price of £1,495 (usual price £1995 - £500 saving) visit www.wdmsummit.com/summer.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here